- Advanced search
- Immuno Portal
- Malaria Portal
Compound class: Synthetic organic
Comment: ML351 is a potent and selective inhibitor of human 15-lipoxygenase-1 . It was used as a probe to demonstrate proof-of-concept of the therapeutic potential of selective inhibition of 15-LOX-1 in stroke models.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
1. Rai G, Joshi N, Perry S, Yasgar A, Schultz L, Jung JE, Liu Y, Terasaki Y, Diaz G, Kenyon V et al.. (2010)
Discovery of ML351, a Potent and Selective Inhibitor of Human 15-Lipoxygenase-1.
Probe Reports from the NIH Molecular Libraries Program,. [PMID:24672829]